Active — Not RecruitingNot Applicable

Enhancing Telemedicine for T2D

United States50 participantsStarted 2025-02-03

Plain-language summary

The goal of this pilot clinical trial is to assess feasibility of an intervention to deliver comprehensive, high-quality diabetes care through telemedicine among adults with type 2 diabetes who use insulin and have multiple chronic health conditions. The main question it aims to answer is: Is an enhanced telemedicine intervention for type 2 diabetes compared to usual telemedicine care feasible? Researchers will compare the enhanced telemedicine intervention to usual telemedicine care to see if there are differences in patient satisfaction or preliminary clinical outcomes. Participants will complete 2-3 telemedicine diabetes care visits over approximately 6 months, as well as complete survey measures with each diabetes care visit. Patients in the intervention group will also receive additional support, including pre-visit preparation phone calls, diabetes self-management education and support aligned with their visits, and post-visit follow-up calls.

Who can participate

Age range

18 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adults 18 years or older * Diagnosis of type 2 diabetes based on abbreviated ICD-10 code E11.X in medical record or self-report * HbA1c greater than or equal to 8% based on most recent value at time of recruitment * Patients must own or have access to a smart phone, tablet, or home computer with data or internet connection that allows access to video-based visits * Patient must use insulin * Patients must have \>2 comorbid chronic health conditions * Be able to provide informed consent * Reside in Pennsylvania Exclusion criteria: * Age over 80 based on date of birth in electronic medical record * Visit with an endocrinologist in the prior 1 years * Dementia, ESRD, malignancy based on abbreviated ICD-10 codes below in medical record or self-report of associated condition * Dementia: A81.0x, F01.5x, F02.8x, F03.9x, F10.27, F10.97, F13.27, F13.97, F18.97, F19.17, F19.27, F19.97, G30.x, G31.0x, G31.1, G31.83, G31.85 * Malignancy, except non-melanoma skin cancer: C00.x-C14.x, C15.x-C26.x, C3x.xx, C40.xx-C41.x, C43.x, C4A.xx, C45.x-C49.xx, C50.xxx, C51.x-C58, C60.x-C63.x, C64.x- C68.x, C69.xx-C72.x, C73-C76.x, C7A.xx, C80.xx-C96.x (except C90.x1, C91.x1, C92.x1, C93.x1, C94.x1, C95.x1) * ESRD N18.6 * Type 1, gestational, or other diabetes based on abbreviated ICD-10 codes below in medical record or self-report of associated condition * Type 1 diabetes: E10.X * Gestational diabetes: O24.X, E08.X * Other diabetes: E09.X, E13.2 * Pregnant or plan…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1This trial is listed as 'active, not recruiting' — does that mean enrollment is already closed, and if so, are there similar telemedicine-based studies for Type 2 diabetes that I might still be able to join?
2Since this study isn't assigned a traditional phase and its primary outcomes focus on recruitment rates and how many people drop out rather than clinical results like blood sugar control, what does that mean for what we'd actually learn about my treatment from participating?
3The trial centers on telemedicine for Type 2 diabetes management — how does a remote care approach like this compare to the in-person diabetes care I'm currently receiving, and could switching to a telemedicine model affect the quality of my monitoring?
4Given that this appears to be a feasibility or logistics-focused study rather than one testing a new drug or device, what would my day-to-day involvement actually look like, and how might it affect my current diabetes management routine?
5Would you recommend I wait for results from this kind of foundational study before considering telemedicine for my own care, or is there already enough evidence to discuss adding telemedicine to my current Type 2 diabetes treatment plan?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Recruitment percentage

Timeframe: 12 months

Loss to follow up

Timeframe: 6 months

Trial details

NCT IDNCT06740435

SponsorUniversity of Pittsburgh

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10

View on ClinicalTrials.gov More Type 2 Diabetes trials